|
About Diabetes
|
First Conference on Science of
Low Carbohydrate.... First Conference on Science of
Low Carbohydrate Diets Reports Benefit for Diabetes Control The first of its kind, the conference assembled a broad array of speakers encompassing the biochemical and clinical fields bearing on the effect of macronutrient composition. Among the notable talks: Donald Layman of the University of Illinois summarized evidence that higher protein/carbohydrate ratios significantly improve weight loss and glycemic control. Daniel T. Stein of Albert Einstein College of Medicine provided new understanding of the convergence of glucose and fatty acids in controlling insulin production, possibly opening the door to reconciling different nutritional strategies. Most impressive from the standpoint of diabetes, were talks by William Yancy, Jr. of Duke University and Frank Nuttall and Mary Gannon of Case Western Reserve who showed that patients on low carbohydrate diets not only consistently showed improvement in glycemic control but required a reduction or elimination of medication. During the audience discussion, practitioners using low carb approaches for diabetes had serious “warnings” that medication should be reduced or eliminated before beginning low carbohydrate diets. Presentations on markers for cardiovascular disease continue to indicate that reducing carbs is, if anything, protective of cardiovascular disease. Khosrow Adeli of the University of Toronto demonstrated the significant lipogenic effect of high fructose diets and pointed out that there is a dramatic increase in dietary fructose consumption, through increase in sucrose (table sugar: 50% fructose) and high-fructose corn syrup. [from unpublished interview]: Richard Feinman, Professor of Biochemistry at Downstate Medical Center and
Chief organizer of the conference said “For the weight loss reports, from the
Westman group at Duke and Volek’s lab in Connecticut: “If some of the low carb
vs. low fat graphs had been labeled drug vs. placebo, everybody would rush out
to buy stock in the drug company.” Whereas many talks were quite technical,
seemingly above the heads of much of the audience, Feinman suggested that “the
most remarkable thing was that almost 200 people of diverse backgrounds hung in
there because they could see that serious science was being brought to bear on
the subjects and, although we are far from having a complete answer, they don’t
want to be dissuaded by the nay-sayers.” Unrestricted educational support for the conference was provided by Kingsbrook Jewish Medical Center, SUNY Downstate Medical Center, Keto Foods, Inc., the Dr. Robert C. Atkins Foundation, The Rumford Foundation, America’s Beef Producers, Kaplan Test Preparation and several Pharmaceutical Companies. Source: Diabetes In Control.com.
|